About this document

HER2 Overexpression in Urothelial Cancer by joaopaulomarchetti is a document available to read on EtoBox.

This study evaluates the overexpression of the HER2 protein in various forms of urothelial carcinoma (UC), particularly focusing on micropapillary urothelial carcinoma (MPUC). Results showed that 56% of MPUC cases exhibited HER2 overexpression, suggesting that these tumors, along with certain invasive and in situ UC cases, may be candidates for targeted anti-HER2 therapy. The findings indicate a potential for using anti-HER2 treatments in bladder cancers, similar to their application in breast and gastric c

Author

joaopaulomarchetti

Language

EN